PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.
PeptideScanner retained ClinicalTrials.gov record NCT00268892 at 2026-11-15T21:52:09.579Z. Its registry update date was 2010-12-24, and PeptideScanner's reviewed identity mapping was degarelix.
PeptideScanner retained ClinicalTrials.gov record NCT00116753 at 2026-11-15T21:52:09.579Z. Its registry update date was 2010-12-10, and PeptideScanner's reviewed identity mapping was degarelix.
PeptideScanner retained ClinicalTrials.gov record NCT00002881 at 2026-07-30T22:25:23.114Z. Its registry update date was 2010-11-09, and PeptideScanner's reviewed identity mapping was leuprolide.
PeptideScanner retained ClinicalTrials.gov record NCT00746031 at 2026-11-15T22:02:39.332Z. Its registry update date was 2010-10-25, and PeptideScanner's reviewed identity mapping was cetrorelix.
PeptideScanner retained ClinicalTrials.gov record NCT01208649 at 2026-07-30T22:25:23.111Z. Its registry update date was 2010-09-24, and PeptideScanner's reviewed identity mapping was exenatide.
PeptideScanner retained ClinicalTrials.gov record NCT00460382 at 2026-11-16T01:41:15.051Z. Its registry update date was 2010-09-17, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00259298 at 2026-07-30T22:25:23.113Z. Its registry update date was 2010-08-11, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained ClinicalTrials.gov record NCT01178996 at 2026-11-15T22:10:40.222Z. Its registry update date was 2010-08-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
PeptideScanner retained ClinicalTrials.gov record NCT01134848 at 2026-11-16T01:34:15.953Z. Its registry update date was 2010-06-02, and PeptideScanner's reviewed identity mapping was secretin.
PeptideScanner retained ClinicalTrials.gov record NCT00638976 at 2026-11-15T21:59:29.646Z. Its registry update date was 2010-05-28, and PeptideScanner's reviewed identity mapping was eptifibatide.
PeptideScanner retained ClinicalTrials.gov record NCT00439829 at 2026-11-15T22:02:39.332Z. Its registry update date was 2010-05-25, and PeptideScanner's reviewed identity mapping was cetrorelix.
PeptideScanner retained ClinicalTrials.gov record NCT00005906 at 2026-07-30T22:25:23.111Z. Its registry update date was 2010-04-30, and PeptideScanner's reviewed identity mapping was octreotide.
PeptideScanner retained ClinicalTrials.gov record NCT00832091 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-03-30, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.
PeptideScanner retained ClinicalTrials.gov record NCT00262054 at 2026-11-15T21:58:19.888Z. Its registry update date was 2010-03-15, and PeptideScanner's reviewed identity mapping was bivalirudin.
PeptideScanner retained ClinicalTrials.gov record NCT00382174 at 2026-11-16T01:44:56.605Z. Its registry update date was 2010-02-01, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.